We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

4 hedge funds and large institutions have $720 invested in ENDRA Life Sciences in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.91% less ownership

Funds ownership: 0.93% → 0.02% (-0.91%)

56% less funds holding

Funds holding: 9 → 4 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

98% less capital invested

Capital invested by funds: $32.9K → $720 (-$32.2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-5
Holders Change %
-55.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$633
2
Bank of America
Bank of America
North Carolina
+$27
3
DB
Danske Bank
Denmark
+$20

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$16K
2
TSS
Two Sigma Securities
New York
-$3.86K
3
TRCT
Tower Research Capital (TRC)
New York
-$3.28K
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.85K
5
Jane Street
Jane Street
New York
-$2.25K

NDRA Hedge Fund Activity: Q4 2024 in Review

4 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2024, worth a combined $720 — down 98% from $32.9K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NDRA and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was UBS Group, opening a new position worth an estimated $633. The largest seller was Virtu Financial, exiting entirely with an estimated $16K sold.

  • 4 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2024, down from 9 in Q3 2024.
  • Funds reported $720 of ENDRA Life Sciences stock for Q4 2024, down 98% quarter-over-quarter.
  • 3 funds opened new ENDRA Life Sciences positions in Q4 2024 and 8 closed out, a net change of -5 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2024 was UBS Group, an estimated $633 added.
  • The largest ENDRA Life Sciences seller in Q4 2024 was Virtu Financial, an estimated $16K sold.

Based on aggregated 13F filings for Q4 2024.